Quick Answer
ProPhase Labs, Inc. reported Operating Income of -$38.63 million for fiscal year 2024.
ProPhase Labs, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$38.63M | -82.0% |
| 2023 | -$21.22M | -189.9% |
| 2022 | $23.59M | +140.7% |
| 2021 | $9.80M | +571.0% |
| 2020 | -$2.08M | +35.8% |
| 2019 | -$3.24M | -98.2% |
| 2018 | -$1.63M | +59.0% |
| 2017 | -$3.99M | -50.2% |
| 2016 | -$2.66M | +25.9% |
| 2015 | -$3.58M | +54.2% |
| 2014 | -$7.83M | -1981.7% |
| 2013 | $416.0K | +137.9% |
| 2012 | -$1.10M | +59.9% |
| 2011 | -$2.74M | +23.8% |
| 2010 | -$3.59M | +8.7% |
| 2009 | -$3.94M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$4.76M | +26.5% | -22.3% |
| June 30, 2025 | -$3.89M | +46.1% | -6.3% |
| March 31, 2025 | -$3.66M | +52.0% | +43.5% |
| September 30, 2024 | -$6.48M | -0.0% | +10.3% |
| June 30, 2024 | -$7.23M | -55.2% | +5.3% |
| March 31, 2024 | -$7.63M | -972.1% | -17.8% |
| September 30, 2023 | -$6.48M | -431.7% | -39.1% |
| June 30, 2023 | -$4.66M | -144.0% | -632.3% |
- ProPhase Labs, Inc. showed a decrease of -82.0% in Operating Income compared to the prior fiscal year.
- Over the 2009–2024 period, ProPhase Labs, Inc.’s operating income has declined by 881.7% (from -$3.94 million to -$38.63 million).
- The most recent figure is from ProPhase Labs, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 1, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: